MRK
Income statement / Annual
Last year (2023), Merck & Co., Inc.'s total revenue was $60.12 B,
an increase of 1.40% from the previous year.
In 2023, Merck & Co., Inc.'s net income was $365.00 M.
See Merck & Co., Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$60.12 B
|
$59.28 B
|
$48.70 B
|
$41.52 B
|
$46.84 B
|
$42.29 B
|
$40.12 B
|
$39.81 B
|
$39.50 B
|
$42.24 B
|
| Cost of Revenue |
$16.13 B |
$17.41 B |
$13.63 B |
$13.62 B |
$14.11 B |
$13.51 B |
$12.78 B |
$13.89 B |
$14.93 B |
$16.77 B |
| Gross Profit |
$43.99 B |
$41.87 B |
$35.08 B |
$27.90 B |
$32.73 B |
$28.79 B |
$27.35 B |
$25.92 B |
$24.56 B |
$25.47 B |
| Gross Profit Ratio |
0.73 |
0.71 |
0.72 |
0.67 |
0.7 |
0.68 |
0.68 |
0.65 |
0.62 |
0.6 |
| Research and Development
Expenses |
$30.53 B
|
$13.55 B
|
$12.25 B
|
$13.40 B
|
$9.87 B
|
$9.75 B
|
$9.98 B
|
$7.19 B
|
$6.70 B
|
$7.18 B
|
| General & Administrative
Expenses |
$8.20 B
|
$7.84 B
|
$7.63 B
|
$7.16 B
|
$8.72 B
|
$8.00 B
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing
Expenses |
$2.30 B
|
$2.20 B
|
$2.00 B
|
$1.80 B
|
$1.90 B
|
$2.10 B
|
$9.83 B
|
$9.76 B
|
$10.31 B
|
$11.61 B
|
| Selling, General &
Administrative Expenses |
$10.50 B
|
$10.04 B
|
$9.63 B
|
$8.96 B
|
$10.62 B
|
$10.10 B
|
$9.83 B
|
$9.76 B
|
$10.31 B
|
$11.61 B
|
| Other Expenses |
$0.00 |
$960.00 M |
$468.00 M |
$469.00 M |
-$139.00 M |
$849.00 M |
$304.00 M |
-$357.00 M |
-$72.00 M |
$12.00 B |
| Operating Expenses |
$43.99 B |
$23.59 B |
$21.88 B |
$22.35 B |
$20.49 B |
$19.85 B |
$19.81 B |
$16.96 B |
$17.02 B |
$18.79 B |
| Cost And Expenses |
$57.16 B |
$41.00 B |
$35.51 B |
$35.97 B |
$34.60 B |
$33.36 B |
$32.59 B |
$30.85 B |
$31.95 B |
$35.55 B |
| Interest Income |
$365.00 M |
$157.00 M |
$36.00 M |
$59.00 M |
$274.00 M |
$343.00 M |
$385.00 M |
$328.00 M |
$289.00 M |
$266.00 M |
| Interest Expense |
$1.15 B |
$962.00 M |
$806.00 M |
$831.00 M |
$893.00 M |
$772.00 M |
$754.00 M |
$693.00 M |
$672.00 M |
$732.00 M |
| Depreciation &
Amortization |
$3.87 B
|
$3.91 B
|
$3.21 B
|
$3.49 B
|
$3.65 B
|
$4.52 B
|
$4.64 B
|
$5.44 B
|
$6.38 B
|
$6.69 B
|
| EBITDA |
$6.91 B
|
$21.32 B
|
$17.90 B
|
$10.18 B
|
$16.01 B
|
$13.99 B
|
$11.95 B
|
$10.79 B
|
$12.45 B
|
$24.71 B
|
| EBITDA Ratio |
0.11 |
0.39 |
0.35 |
0.23 |
0.27 |
0.24 |
0.21 |
0.23 |
0.2 |
0.45 |
| Operating Income Ratio
|
0.05
|
0.33
|
0.28
|
0.15
|
0.2
|
0.14
|
0.09
|
0.09
|
0.04
|
0.3
|
| Total Other
Income/Expenses Net |
-$1.07 B
|
-$1.84 B
|
$680.00 M
|
$315.00 M
|
$3.54 B
|
-$230.00 M
|
-$986.00 M
|
$1.08 B
|
-$2.15 B
|
$4.77 B
|
| Income Before Tax |
$1.89 B |
$16.44 B |
$13.88 B |
$8.79 B |
$11.46 B |
$8.70 B |
$6.75 B |
$7.50 B |
$5.40 B |
$17.28 B |
| Income Before Tax Ratio
|
0.03
|
0.28
|
0.28
|
0.21
|
0.24
|
0.21
|
0.17
|
0.19
|
0.14
|
0.41
|
| Income Tax Expense |
$1.51 B |
$1.92 B |
$1.52 B |
$1.71 B |
$1.69 B |
$2.51 B |
$4.16 B |
$1.79 B |
$942.00 M |
$5.35 B |
| Net Income |
$365.00 M |
$14.52 B |
$13.05 B |
$7.07 B |
$9.84 B |
$6.22 B |
$2.57 B |
$5.69 B |
$4.44 B |
$11.92 B |
| Net Income Ratio |
0.01 |
0.24 |
0.27 |
0.17 |
0.21 |
0.15 |
0.06 |
0.14 |
0.11 |
0.28 |
| EPS |
0.14 |
5.73 |
5.16 |
2.79 |
3.84 |
2.4 |
0.95 |
2.07 |
1.6 |
4.2 |
| EPS Diluted |
0.14 |
5.71 |
5.14 |
2.78 |
3.82 |
2.32 |
0.93 |
2.04 |
1.56 |
4.07 |
| Weighted Average Shares
Out |
$2.61 B
|
$2.53 B
|
$2.53 B
|
$2.53 B
|
$2.57 B
|
$2.59 B
|
$2.70 B
|
$2.75 B
|
$2.78 B
|
$2.84 B
|
| Weighted Average Shares
Out Diluted |
$2.55 B
|
$2.54 B
|
$2.54 B
|
$2.54 B
|
$2.58 B
|
$2.68 B
|
$2.75 B
|
$2.79 B
|
$2.84 B
|
$2.93 B
|
| Link |
|
|
|
|
|
|
|
|
|
|
